These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17495632)

  • 1. Therapeutic approaches to inflammation in neurodegenerative disease.
    Klegeris A; McGeer EG; McGeer PL
    Curr Opin Neurol; 2007 Jun; 20(3):351-7. PubMed ID: 17495632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common anti-inflammatory drugs are potentially therapeutic for Parkinson's disease?
    Asanuma M; Miyazaki I
    Exp Neurol; 2007 Aug; 206(2):172-8. PubMed ID: 17599833
    [No Abstract]   [Full Text] [Related]  

  • 3. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
    Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging enhances the neuroinflammatory response and alpha-synuclein nitration in rats.
    Choi DY; Zhang J; Bing G
    Neurobiol Aging; 2010 Sep; 31(9):1649-53. PubMed ID: 18986737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial reactions in Parkinson's disease.
    McGeer PL; McGeer EG
    Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation.
    George S; Brundin P
    J Parkinsons Dis; 2015; 5(3):413-24. PubMed ID: 26406122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.
    Asanuma M; Miyazaki I
    Expert Rev Neurother; 2006 Sep; 6(9):1313-25. PubMed ID: 17009919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-autonomous cell death in Parkinson's disease.
    Dawson TM
    Lancet Neurol; 2008 Jun; 7(6):474-5. PubMed ID: 18485311
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel anti-inflammatory and neuroprotective agents for Parkinson's disease.
    Lu L; Li F; Wang X
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):232-40. PubMed ID: 20015029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inflammatory pathomechanism for Parkinson's disease?
    Wersinger C; Sidhu A
    Curr Med Chem; 2006; 13(5):591-602. PubMed ID: 16515523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation.
    Chen HQ; Jin ZY; Li GH
    Neurosci Lett; 2007 May; 417(2):112-7. PubMed ID: 17399896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids.
    Suk K
    Neurosignals; 2005; 14(1-2):23-33. PubMed ID: 15956812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
    Hald A; Lotharius J
    Exp Neurol; 2005 Jun; 193(2):279-90. PubMed ID: 15869932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-modifying drugs and Parkinson's disease.
    Allain H; Bentué-Ferrer D; Akwa Y
    Prog Neurobiol; 2008 Jan; 84(1):25-39. PubMed ID: 18037225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory mechanism of ginseng saponins in activated microglia.
    Park JS; Park EM; Kim DH; Jung K; Jung JS; Lee EJ; Hyun JW; Kang JL; Kim HS
    J Neuroimmunol; 2009 Apr; 209(1-2):40-9. PubMed ID: 19232442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA.
    Melton LM; Keith AB; Davis S; Oakley AE; Edwardson JA; Morris CM
    Glia; 2003 Oct; 44(1):1-12. PubMed ID: 12951652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs.
    Bassani TB; Vital MA; Rauh LK
    Arq Neuropsiquiatr; 2015 Jul; 73(7):616-23. PubMed ID: 26200058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic regulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216: implications for chronic treatments of neurodegenerative diseases.
    Bernardo A; Gasparini L; Ongini E; Minghetti L
    Neurobiol Dis; 2006 Apr; 22(1):25-32. PubMed ID: 16307889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.